|
2025
|
Invention
|
Insulin derivative.
Disclosed is an acylated insulin, a pharmaceutical formulation thereof, a ph... |
|
|
Invention
|
Synthesis and use of novel proteolysis chimera compound targeting interleukin-1 receptor-associat... |
|
2024
|
Invention
|
Therapeutic use of pharmaceutical composition comprising insulin derivative. The present inventio... |
|
|
Invention
|
Glp-1 compound for weight loss. The present invention relates to a GLP-1 compound for weight loss. |
|
|
Invention
|
Glp-1 compound for lowering sugar levels. a GLP-1 compound for lowering sugar levels. |
|
|
Invention
|
Long-acting glp-1 compound.
GLP-1 derivatives are described. Also described are pharmaceutical c... |
|
2023
|
Invention
|
Anti-tslp antibody and use thereof. Provided is an antibody specifically binding to TSLP or an an... |
|
|
Invention
|
Antibody against coagulation factor xi and/or activated form factor xia thereof, and use thereof.... |
|
|
Invention
|
Anti-ox40 antibody and application thereof. Provided are an antibody binding to human OX40 and an... |
|
|
Invention
|
Deuterated compound, preparation method therefor and use thereof. Provided are a deuterated compo... |
|
|
Invention
|
Cereblon e3 ubiquitin ligase inhibitor.
The present invention relates to a compound represented ... |
|
|
Invention
|
Cereblon e3 ubiquitin ligase inhibitor. The present invention relates to a compound represented b... |
|
|
Invention
|
New protac compound. The present invention relates to a bifunctional PROTAC compound having a str... |
|
|
Invention
|
Acylated insulin.
Provided are a new acylated insulin, a pharmaceutical preparation thereof, a p... |
|
|
Invention
|
Acylated insulin. Provided are a new acylated insulin, a pharmaceutical preparation thereof, a ph... |
|
|
Invention
|
Exatecan derivative-antibody conjugate and medical use thereof.
Disclosed in the present inventi... |
|
|
Invention
|
Exatecan derivative-antibody conjugate and medical use thereof. Disclosed in the present inventio... |
|
2022
|
Invention
|
Compound as shp2 inhibitor, and preparation method therefor and use thereof. Provided are a compo... |
|
|
Invention
|
Pharmaceutical use of cdk4/6 inhibitor. Disclosed are a method for treating cancer with a CDK4/6 ... |
|
|
Invention
|
Anti-rsv antibody and application thereof.
Provided are an antibody having effective neutralizin... |
|
|
Invention
|
Anti-rsv antibody and application thereof. Provided are an antibody having effective neutralizing... |
|
|
Invention
|
Multispecific antibody, and use thereof. A multispecific antibody, comprising a first antigen bin... |
|
|
Invention
|
Stable formulation comprising anti-il-4r antibody. A stable pharmaceutical formulation comprising... |
|
|
Invention
|
Pharmaceutical composition containing glp-1 compound.
The present invention relates to a pharmac... |
|
|
Invention
|
Acylated insulin-containing pharmaceutical composition.
Disclosed in the present invention is an... |
|
|
Invention
|
Pharmaceutical composition of pcsk9 inhibitor and glp-1 receptor agonist.
The present invention ... |
|
|
Invention
|
Pharmaceutical composition containing glp-1 compound. The present invention relates to a pharmace... |
|
|
Invention
|
Pharmaceutical composition of pcsk9 inhibitor and glp-1 receptor agonist. The present invention r... |
|
|
Invention
|
Acylated insulin-containing pharmaceutical composition. Disclosed in the present invention is an ... |
|
|
Invention
|
Pharmaceutical use of cdk 4/6 inhibitor.
Provided are a method for treating a cancer by a CDK4/6... |
|
|
Invention
|
Pharmaceutical use of cdk4/6 inhibitor. Provided are a method for treating a cancer by a CDK4/6 i... |
|
|
Invention
|
Deuterated compound as cdk4/6 inhibitor. Provided are a deuterated compound as a CDK4/6 inhibitor... |
|
2021
|
Invention
|
Methods for editing bcl11a gene in hematopoietic stem/progenitor cells. Provided are a method for... |
|
|
Invention
|
Pharmaceutical composition containing cdk4/6 inhibitor. Disclosed is a pharmaceutical composition... |
|
2020
|
Invention
|
Insulin derivative.
Provided is an insulin derivative, a pharmaceutical formulation thereof, a p... |
|
|
Invention
|
Long-acting glp-1 compound.
A novel GLP-1 derivative, compared with GLP-1 derivatives such as li... |
|
|
Invention
|
Insulin derivative.
The present invention relates to a novel insulin derivative, a pharmaceutica... |
|
|
Invention
|
Methods for preparing cdk4/6 inhibitor and salt and intermediate thereof.
The present invention ... |
|
|
Invention
|
Bispecific chimeric antigen receptor.
The present invention relates to a bispecific chimeric ant... |
|
|
Invention
|
Salts of a compound, crystal forms of the salts and preparation method and use thereof.
The pres... |
